We are live on
!
Find out more
HAM
HHR Asset Management Portfolio holdings
AUM
$552M
1-Year Est. Return
15.61%
This Fund
S&P 500
This Quarter
Est. Return
+11.5%
1 Year Est. Return
-15.61%
3 Year Est. Return
+76.29%
5 Year Est. Return
+157.16%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$58.3M
(+5.9%)
Cap. Flow
-$50.7M
Cap. Flow
% of AUM
-4.84%
Top 10 Holdings %
Top 10 Hldgs %
45.63%
Holding
39
New
5
Increased
2
Reduced
29
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$44.2M |
| 2 |
Netflix
NFLX
|
+$44.1M |
| 3 |
Elastic
ESTC
|
+$43.9M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$20.1M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$20M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$51.6M |
| 2 |
TWOU
2U Inc
TWOU
|
+$17.3M |
| 3 |
Ulta Beauty
ULTA
|
+$17M |
| 4 |
Tyler Technologies
TYL
|
+$14.1M |
| 5 |
RH
RH
|
+$12.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 40.48% |
| 2 | Technology | 33.56% |
| 3 | Communication Services | 13.23% |
| 4 | Financials | 8.7% |
| 5 | Healthcare | 2.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
26
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $18.7M | 1.79% |
239,775
-57,085
| -19% | -$4.41M |
|
27
CRISPR Therapeutics
CRSP
$4.73B
| $3.57M | 0.34% |
58,670
-5,860
| -9% | -$320K |
|
|
BOLD
28
DELISTED
Audentes Therapeutics, Inc
BOLD
| $3.48M | 0.33% |
58,230
-5,810
| -9% | -$218K |
|
29
Editas Medicine
EDIT
$396M
| $2.48M | 0.24% |
83,850
-8,380
| -9% | -$209K |
|
30
MeiraGTx Holdings
MGTX
$1.09B
| $2.33M | 0.22% |
116,604
-11,647
| -9% | -$199K |
|
31
Allogene Therapeutics
ALLO
$649M
| $2.1M | 0.2% |
80,690
-8,070
| -9% | -$222K |
|
32
Q32 Bio
QTTB
$466M
| $1.6M | 0.15% |
4,286
-428
| -9% | -$123K |
|
33
Regenxbio
RGNX
$620M
| $1.57M | 0.15% |
38,350
-3,830
| -9% | -$151K |
|
34
Voyager Therapeutics
VYGR
$183M
| $1.44M | 0.14% |
103,368
-10,330
| -9% | -$150K |
|
|
SGMO
35
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.44M | 0.14% |
172,160
-17,200
| -9% | -$158K |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| $1.21M | 0.12% |
1,066
-107
| -9% | -$116K |
|
|
37
Tesla
TSLA
$1.23T
| – | – |
-3,212,475
| Closed | -$51.6M |
|
|
38
Ulta Beauty
ULTA
$22B
| – | – |
-68,020
| Closed | -$17M |
|
|
TWOU
39
DELISTED
2U Inc
TWOU
| – | – |
-35,383
| Closed | -$17.3M |
|
Similar funds
HT
SM
GH
TM
FC
FC
VR
MCM
HHR Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, HHR Asset Management held 39 positions worth $1.05B, up 5.9% from $989M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
HHR Asset Management withdrew a net $50.7M in Q4 2019, closing 3 positions and reducing 29 holdings. Its most notable exit was Tesla, an estimated $51.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 44% a quarter earlier, followed by Technology and Communication Services.
Against the trend, HHR Asset Management opened a new position in Starbucks worth $45.6M.
- HHR Asset Management's largest Q4 2019 buy was Starbucks: 518,338 shares worth $45.6M.
- HHR Asset Management added most to Nike in Q4 2019, an estimated $10.8M increase.
- HHR Asset Management's biggest Q4 2019 reduction was Tyler Technologies, cutting an estimated $14.1M.
- HHR Asset Management fully exited Tesla in Q4 2019, selling an estimated $51.6M.
- HHR Asset Management's ten largest holdings make up 46% of its $1.05B portfolio in Q4 2019.
- HHR Asset Management opened 5 new positions and closed 3 in Q4 2019.
- HHR Asset Management's portfolio value rose 5.9% quarter-over-quarter to $1.05B.
Based on HHR Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.